Ronan O’Dwyer

Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain

Mischa Müller, Kenneth Saunders, Christopher Grace et al. · mAbs · 2012 · 87 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors

Adam P. Curnock, Giovanna Bossi, Jyothi Kumaran et al. · JCI Insight · 2021 · 79 citations · Full text

Life Sciences, Immunology, Medicinal Chemistry +17

Cloning, expression and characterisation of a single-chain Fv antibody fragment against domoic acid in Escherichia coli

Xuejun Hu, Ronan O’Dwyer, J. Gerard Wall · Journal of Biotechnology · 2005 · 32 citations

Pharmacy, Microbiology, Molecular Biology +16

Generation and Isolation of Target-Specific Single-Domain Antibodies from Shark Immune Repertoires

Mischa Müller, Ronan O’Dwyer, Marina Kovaleva et al. · Methods in molecular biology · 2012 · 31 citations

Life Sciences, Immunology, Cellular Immunology +8

Engineering of Cysteine Residues Leads to Improved Production of a Human Dipeptidase Enzyme in E. coli

Ronan O’Dwyer, Rafia Razzaque, Xuejun Hu et al. · Applied Biochemistry and Biotechnology · 2008 · 15 citations

Life Sciences, Biochemistry, Biotechnology +15